Learn more about our Diagnostics work.
WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®) today released the following statement from Susan Van Meter, executive director of AdvaMedDx®, in response to comments on COVID-19 serology/antibody testing at today’s hearing…
AdvaMedDx® developed the VALID Assessment Framework as a tool to analyze the legislation.
Doctors, nurses and health care providers fighting on the front lines against the coronavirus are modern-day heroes. Every day they selflessly risk their own health to provide essential care to…
This infographic depicts the process of COVID-19 diagnostic tests from patient sample to test results.
The VALID Act seeks to modernize FDA oversight of in vitro diagnostics.
WASHINGTON, D.C. – Several diagnostics companies have received or will soon receive FDA Emergency Use Authorizations (EUA) that will provide crucial capacity for the U.S. to significantly ramp up testing for the coronavirus (COVID-19). …
On March 5, 2020, the VALID Act was introduced in the Senate and House.
WASHINGTON, D.C. – AdvaMed® President and CEO Scott Whitaker and AdvaMedDx® Executive Director Susan Van Meter issued the following statements upon introduction today in the House and Senate of the Verifying Accurate,…
WASHINGTON, D.C. – AdvaMed® President and CEO Scott Whitaker and AdvaMedDx® Executive Director Susan Van Meter issued the following statements upon congressional passage of the Laboratory Access for Beneficiaries (LAB) Act as part of the…
AdvaMedDx® Test to Treatment fact sheets and social media-ready value facts communicate the value of diagnostics.